Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical efficacy of non-invasive ventilation and modafinil on excessive daytime sleepiness in myotonic dystrophy type 1
2016-000601-36Phase 3Completed
- Sponsor
- Fondazione Serena
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of modafinil in myotonic dystrophy type 1 (DM1), sponsored by Fondazione Serena. Primary endpoint: Improvement of excessive daytime sleepiness. Started Jun 2021; status: completed.
02
Drugs
modafinil
03
Conditions
myotonic dystrophy type 1 (DM1)
Beyond the preview
Go deeper on 2016-000601-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000601-36.